Apple's next trick? Wearable tech, analyst says
Apple's next big venture could be wearable technology, starting with a “smart watch.”
Piper Jaffray analyst Gene Munster said on Wednesday he expects Apple to jump into the wearable tech market some time in 2014 or beyond.
“We believe that wearable computers will ultimately be a major future trend,” Munster said in a note to investors. “Longer term (over the next 10-plus years), wearable computers could eventually replace the iPhone and smartphones in general.”
Munster's predictions occur on the heels of rumors last week that the Cupertino, Calif., tech giant is working with Intel on a Bluetooth watch that would work with the iPhone.
Besides wearable tech, Munster also had quite a few other Apple predictions.
He said he expects Apple to start selling a TV in time for the next holiday shopping season, priced between $1,500 and $2,000. The model would have a screen measuring between 42 and 55 inches and include Apple's Siri and FaceTime features.
In addition to a full TV, Munster also said he expects Apple to update its Apple TV device and introduce a TV app store in early 2013. Around the same time, Munster said he expects Apple to release a radio service, which Apple is reportedly working on.
Additionally, Munster said he expects Apple will bring its high-resolution Retina display technology to at least two more of its products. He said the first would be the iPad mini, with a Retina model in early 2013, and then the MacBook Air laptop, with a Retina model in the summer.
Apple stocks closed at $549.03, up $16.87.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Construction picks up, but workers hard to find
- Oakland firm Qualaris Healthcare’s software saves time in hospitals
- Consumer spending dinged by declining gas prices
- Lumber Liquidators shares plunge 25%
- Mud serves as multipurpose tool in $100B shale industry
- Mylan completes inversion with Abbott to move headquarters to Netherlands, lower taxes
- Nasdaq climbs over 5,000 points ... 15 years later
- Pittsburgh gas pump prices up nearly 9 cents
- Bill Gates repeats at top of Forbes’ list of billionaires
- Rue21 adjusts for tough market
- Mylan closes $5.3B tax-lowering deal with Abbott Labs